| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| A Romigi, M Caccamo, F Testa, D Ticconi, S Cappellano, B Di Gioia, G Vitrani, I Rosenzweig, D Centonz. Muscle atonia index during multiple sleep latency test: A possible marker to differentiate narcolepsy from other hypersomnias. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology. vol 149. 2023-03-04. PMID:36870217. |
our study aimed to determine the changes in muscle tone (atonia index, ai) at different levels of vigilance during the entire multiple sleep latency test (mslt) and each nap in people with narcolepsy type 1 (nt1) and 2 (nt2) compared with other hypersomnias and its potential diagnostic value. |
2023-03-04 |
2023-08-14 |
Not clear |
| Maria Paola Mogavero, Lourdes M DelRosso, Oliviero Bruni, Michele Salemi, Maria Salsone, Fabiana Novellino, Marco Zucconi, Luigi Ferini Strambi, Raffaele Ferr. Genetics and epigenetics of rare hypersomnia. Trends in genetics : TIG. 2023-02-26. PMID:36842900. |
herein we focus on connections between genetics and some central disorders of hypersomnolence - narcolepsy types 1 and 2 (nt1, nt2), idiopathic hypersomnia (ih), and kleine-levin syndrome (kls) - for a better understanding of their etiopathogenetic mechanisms and a better diagnostic and therapeutic definition. |
2023-02-26 |
2023-08-14 |
Not clear |
| Alessandra D'Alterio, Marco Menchetti, Corrado Zenesini, Andrea Rossetti, Luca Vignatelli, Christian Franceschini, Giorgia Varallo, Fabio Pizza, Giuseppe Plazzi, Francesca Ingravall. Resilience and its correlates in patients with narcolepsy type 1. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2023-01-23. PMID:36689313. |
this study aimed to explore resilience and its possible association with sociodemographic and clinical features in patients with narcolepsy type 1 (nt1). |
2023-01-23 |
2023-08-14 |
Not clear |
| b' Eva Feketeov\\xc3\\xa1, Jozef Draga\\xc5\\xa1ek, Katar\\xc3\\xadna Klobu\\xc4\\x8dn\\xc3\\xadkov\\xc3\\xa1, Peter \\xc4\\x8eurd\\xc3\\xadk, Simona \\xc4\\x8carnakovi\\xc4\\x8d, Miriam Slavkovsk\\xc3\\xa1, Martina Chylov\\xc3\\xa. Psychotic Episode and Schizophrenia in Slovakian Narcolepsy Database. Brain sciences. vol 13. issue 1. 2023-01-21. PMID:36672025.' |
narcolepsy type 1 (nt1), a central disorder of hypersomnolence, is associated with mood, anxiety or hyperactivity mental disorders. |
2023-01-21 |
2023-08-14 |
Not clear |
| b' Eva Feketeov\\xc3\\xa1, Jozef Draga\\xc5\\xa1ek, Katar\\xc3\\xadna Klobu\\xc4\\x8dn\\xc3\\xadkov\\xc3\\xa1, Peter \\xc4\\x8eurd\\xc3\\xadk, Simona \\xc4\\x8carnakovi\\xc4\\x8d, Miriam Slavkovsk\\xc3\\xa1, Martina Chylov\\xc3\\xa. Psychotic Episode and Schizophrenia in Slovakian Narcolepsy Database. Brain sciences. vol 13. issue 1. 2023-01-21. PMID:36672025.' |
comorbid schizophrenia with nt1 in the slovakian narcolepsy database was within the prevalence expected in the general population. |
2023-01-21 |
2023-08-14 |
Not clear |
| R Peraita-Adrados, J M Bellón, L Lillo-Triguero, P López-Esteban, P Medrano-Martíne. Long-term follow-up on the effects of sodium oxybate on daytime sleepiness and sleep architecture in patients with narcolepsy type 1. Revista de neurologia. vol 76. issue 2. 2023-01-12. PMID:36631962. |
sodium oxybate (sxb) was administered for the first time in 1979 in 16 patients with narcolepsy with cataplexy (nt1) that improved up to 20 months. |
2023-01-12 |
2023-08-14 |
Not clear |
| Zhao Liu, Ruiqian Guan, Limin Pa. TCM syndrome differentiation and treatment of narcolepsy based on neurobiological mechanism: A review. Medicine. vol 101. issue 49. 2023-01-10. PMID:36626491. |
narcolepsy is divided into narcolepsy type 1 (nt1) and narcolepsis type 2 (nt2). |
2023-01-10 |
2023-08-14 |
human |
| Zhao Liu, Ruiqian Guan, Limin Pa. TCM syndrome differentiation and treatment of narcolepsy based on neurobiological mechanism: A review. Medicine. vol 101. issue 49. 2023-01-10. PMID:36626491. |
human leukocyte antigen alleles have been found to strongly influence the development of narcolepsy, with more than 90% of nt1 patients carrying the human leukocyte antigen ii allele dqb1*06:02. |
2023-01-10 |
2023-08-14 |
human |
| Gerard Mayà, Carles Gaig, Alex Iranzo, Joan Santamari. Temporal distribution of sleep onset REM periods and N3 sleep in the MSLT and night polysomnogram of narcolepsy type 1 and other hypersomnias. Sleep medicine. vol 102. 2023-01-02. PMID:36592569. |
we studied the temporal distribution of soremps and associated sleep stages in the mslt of patients with narcolepsy type 1 (nt1) and other hypersomnias (oh). |
2023-01-02 |
2023-08-14 |
Not clear |
| Rannveig Viste, Louise F Follin, Birgitte R Kornum, Benedicte A Lie, Marte K Viken, Per M Thorsby, Terje Rootwelt, Julie A E Christensen, Stine Knudsen-Heie. Increased muscle activity during sleep and more RBD symptoms in H1N1-(Pandemrix)-vaccinated narcolepsy type 1 patients compared with their nonnarcoleptic siblings. Sleep. 2022-12-23. PMID:36562330. |
narcolepsy type 1 (nt1) is characterized by unstable sleep-wake and muscle tonus regulation during sleep. |
2022-12-23 |
2023-08-14 |
Not clear |
| Lanxiang Wu, Qingqing Zhan, Qian Liu, Suheng Xie, Sheng Tian, Liang Xie, Wei W. Abnormal Regional Spontaneous Neural Activity and Functional Connectivity in Unmedicated Patients with Narcolepsy Type 1: A Resting-State fMRI Study. International journal of environmental research and public health. vol 19. issue 23. 2022-12-11. PMID:36497558. |
previous resting-state functional magnetic resonance imaging (fmri) studies have mainly focused on cerebral functional alteration in processing different emotional stimuli in patients with narcolepsy type 1 (nt1), but were short of exploration of characteristic brain activity and its remote interaction patterns. |
2022-12-11 |
2023-08-14 |
Not clear |
| Matteo Cesari, Kristin Egger, Ambra Stefani, Melanie Bergmann, Abubaker Ibrahim, Elisabeth Brandauer, Birgit Högl, Anna Heidbrede. Differentiation of central disorders of hypersomnolence with manual and artificial-intelligence-derived polysomnographic measures. Sleep. 2022-12-01. PMID:36455881. |
we included video-polysomnography data of 40 narcolepsy type 1 (nt1), 26 narcolepsy type 2 (nt2), 23 idiopathic hypersomnia (ih) patients and 54 subjects with subjective excessive daytime sleepiness (seds). |
2022-12-01 |
2023-08-14 |
human |
| Eva Wiberg Torstensen, Niels Christian Haubjerg Østerby, Fabio Pizza, Giuseppe Plazzi, Elena Antelmi, Monica Moresco, Emmanuel Mignot, Niklas Rye Jørgensen, Gitte Lund Christensen, Benedikte Wanscher, Birgitte Rahbek Kornum, Poul Jørgen Jennu. Repeated measures of hypocretin-1 in Danish and Italian patients with narcolepsy and in controls. Sleep medicine. vol 101. 2022-11-25. PMID:36427467. |
we aimed to revalidate csf-hcrt-1 cut-offs for narcolepsy type 1 (nt1) diagnosis and to evaluate temporal changes in csf-hcrt-1 levels in patients suspected of having central hypersomnia. |
2022-11-25 |
2023-08-14 |
Not clear |
| Hamza O Dhafar, Ahmed S BaHamma. Body Weight and Metabolic Rate Changes in Narcolepsy: Current Knowledge and Future Directions. Metabolites. vol 12. issue 11. 2022-11-24. PMID:36422261. |
patients with narcolepsy, especially nt1, have been found to have a high prevalence of obesity and other metabolic derangements. |
2022-11-24 |
2023-08-14 |
Not clear |
| João H C Campos, Ana C R Aguilar, Fernando Antoneli, Giselle Truzzi, Marcelo R S Briones, Renata C Ferreira, Fernando M S Coelh. Whole-genome analysis of monozygotic Brazilian twins discordant for type 1 narcolepsy: a case report. BMC neurology. vol 22. issue 1. 2022-11-19. PMID:36401198. |
narcolepsy type 1 (nt1) is a rare and chronic neurological disease characterized by sudden sleep attacks, overwhelming daytime drowsiness, and cataplexy. |
2022-11-19 |
2023-08-14 |
Not clear |
| Sona Nevsimalova, Jelena Skibova, Karolina Galuskova, Iva Prihodova, Simona Dostalova, Eszter Maurovich-Horvat, Karel Šonk. Central Disorders of Hypersomnolence: Association with Fatigue, Depression and Sleep Inertia Prevailing in Women. Brain sciences. vol 12. issue 11. 2022-11-11. PMID:36358417. |
one hundred and forty-eight subjects (female 63%) were divided into narcolepsy type 1 (nt1; n = 87, female = 61%), narcolepsy type 2 (nt2; n = 22, female = 59%), and idiopathic hypersomnia (ih; n = 39, female = 69%). |
2022-11-11 |
2023-08-14 |
human |
| Giorgia Varallo, Alessandro Musetti, Anita D'Anselmo, Alessio Gori, Emanuele Maria Giusti, Fabio Pizza, Gianluca Castelnuovo, Giuseppe Plazzi, Christian Franceschin. Exploring Addictive Online Behaviors in Patients with Narcolepsy Type 1. Healthcare (Basel, Switzerland). vol 10. issue 11. 2022-11-11. PMID:36360510. |
narcolepsy type 1 (nt1) is a rare neurological sleep disorder caused by the loss of neurons that produce hypocretin-a peptide that plays a crucial role in addictive behaviors. |
2022-11-11 |
2023-08-14 |
Not clear |
| Sofia M Buonocore, Robbert G van der Mos. Narcolepsy and H1N1 influenza immunology a decade later: What have we learned? Frontiers in immunology. vol 13. 2022-10-31. PMID:36311717. |
narcolepsy with cataplexy (defined as type-1 narcolepsy, nt1) is characterized by an irreversible and chronic deficiency of hypocretin peptides in the hypothalamus. |
2022-10-31 |
2023-08-14 |
Not clear |
| Francisco J Martinez-Orozco, Miguel Fernandez-Arquero, Jose L Vicario, Laura Lillo-Triguero, Elena Ameyugo, Rosa Peraita-Adrado. Long-Term Outcome of a Series of Patients With Narcolepsy Type 1 and Comorbidity With Immunopathological and Autoimmune Diseases. Journal of clinical medicine research. vol 14. issue 8. 2022-09-21. PMID:36128006. |
the aim of this study was to evaluate the long-term outcome of our series of narcolepsy type 1 (nt1) patients with comorbid autoimmune diseases (ads) and other immunopathological diseases (ids), focusing on the incidence of new ads and ids in this sample. |
2022-09-21 |
2023-08-14 |
Not clear |
| Takashi Ishikawa, Hiroe Hara, Ayumi Kawano, Haruhide Kimur. Danavorexton, a selective orexin 2 receptor agonist, provides a symptomatic improvement in a narcolepsy mouse model. Pharmacology, biochemistry, and behavior. 2022-09-15. PMID:36108771. |
narcolepsy type 1 (nt1), caused by loss of orexin neurons, is a neurological disorder characterized by excessive daytime sleepiness, cataplexy, disrupted nighttime sleep, hypnagogic/hypnopompic hallucinations and sleep paralysis, as well as a high risk of obesity. |
2022-09-15 |
2023-08-14 |
mouse |